Related Experiment Video
Updated: May 29, 2025

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
Published on: September 26, 2018
[Cardiovascular risk stratification: from algorithms to clinical phenotype]
Furio Colivicchi1, Stefania Angela Di Fusco1
1U.O.C. Cardiologia Clinica e Riabilitativa, Presidio Ospedaliero San Filippo Neri - ASL Roma 1, Roma.
Insights
Stratifying cardiovascular risk is crucial for prevention. European Society of Cardiology (ESC) guidelines offer tools like SCORE2 and SCORE2-Diabetes for accurate risk assessment in various populations.
Area of Science:
- Cardiology
- Preventive Medicine
- Risk Stratification
Context:
- Cardiovascular disease prevention requires accurate individual risk assessment.
- Atherosclerotic cardiovascular diseases stem from multiple risk factors.
- Non-modifiable (age) and modifiable (cholesterol, diabetes, blood pressure, smoking, weight) factors are considered.
Purpose:
- To outline the importance of cardiovascular risk stratification.
- To introduce European Society of Cardiology (ESC) risk scores for different demographics.
- To highlight the utility of the ESC CVD Risk Calculation application.
Summary:
- Individual cardiovascular risk stratification is essential for primary and secondary prevention.
- ESC guidelines recommend SCORE2 (ages 40-69), SCORE2-OP (≥70), and SCORE2-Diabetes for risk assessment.
- The ESC CVD Risk Calculation app facilitates rapid risk estimation for apparently healthy individuals and diabetics.
Impact:
- Facilitates appropriate implementation of cardiovascular prevention strategies.
- Enables personalized risk assessment for targeted interventions.
- Supports clinical decision-making for managing cardiovascular risk.
Abstract:
For an appropriate implementation of both primary and secondary cardiovascular prevention strategies, stratification of the individual cardiovascular risk is recommended. Given that atherosclerotic cardiovascular diseases have a multifactorial origin, risk stratification should take into consideration several risk factors, both non-modifiable ones such as age, and modifiable ones, such as cholesterol levels, diabetes, blood pressure levels, cigarette smoking, and body weight. For apparently healthy individuals, to define the risk of each subject of having a cardiovascular event within 10 years, the European Society of Cardiology (ESC) guidelines recommend the use of specific risk scores depending on patient's age (SCORE2 between 40 and 69 years, SCORE2-OP ≥70 years). For diabetic patients without evidence of cardiovascular disease, the use of the SCORE2-Diabetes is recommended. In clinical practice, the use of the ESC CVD Risk Calculation application, by entering all the parameters required by the different scores, allows a rapid estimate of individual risk. Patients with known atherosclerotic cardiovascular disease have a very high cardiovascular risk.
Related Concept Videos
Cardiovascular Drugs: Classification based on Therapeutic Indications
Assessment of the Cardiovascular System I: Subjective Data
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Pre-Procedural Guidelines for Assessing Blood Pressure

